Literature DB >> 19751877

Hep G2 is a hepatoblastoma-derived cell line.

Dolores López-Terrada, Sau Wai Cheung, Milton J Finegold, Barbara B Knowles.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19751877     DOI： 10.1016/j.humpath.2009.07.003

Source DB:  PubMed          Journal:  Hum Pathol        ISSN： 0046-8177            Impact factor:   3.466


× No keyword cloud information.
  116 in total

1.  Utilizing ethacrynic acid and ciclopirox olamine in liver cancer.

Authors:  Ahmad M Al-Dali; Hans Weiher; Ingo G H Schmidt-Wolf
Journal:  Oncol Lett       Date:  2018-09-20       Impact factor: 2.967

2.  In silico and in vivo models for Qatari-specific classical homocystinuria as basis for development of novel therapies.

Authors:  Hesham M Ismail; Navaneethakrishnan Krishnamoorthy; Nader Al-Dewik; Hatem Zayed; Nura A Mohamed; Valeria Di Giacomo; Sapna Gupta; Johannes Häberle; Beat Thöny; Henk J Blom; Waren D Kruger; Tawfeg Ben-Omran; Gheyath K Nasrallah
Journal:  Hum Mutat       Date:  2018-11-23       Impact factor: 4.878

3.  Epidermal growth factor receptor/heme oxygenase-1 axis is involved in chemoresistance to cisplatin and pirarubicin in HepG2 cell lines and hepatoblastoma specimens.

Authors:  Takashi Kobayashi; Masayuki Kubota; Yoshiaki Kinoshita; Yuki Arai; Toshiyuki Oyama; Naoki Yokota; Koichi Saito; Yasunobu Matsuda; Mami Osawa
Journal:  Pediatr Surg Int       Date:  2019-09-26       Impact factor: 1.827

4.  HOTAIR contributes to the growth of liver cancer via targeting miR-217.

Authors:  Li-Ping Wang; Jun-Ping Wang; Xin-Ping Wang
Journal:  Oncol Lett       Date:  2018-03-23       Impact factor: 2.967

5.  MicroRNA-146a-5p enhances ginsenoside Rh2-induced anti-proliferation and the apoptosis of the human liver cancer cell line HepG2.

Authors:  Weiwen Chen; Shuai Chu; Haixia Li; Yurong Qiu
Journal:  Oncol Lett       Date:  2018-07-31       Impact factor: 2.967

Review 6.  Natural compounds for pediatric cancer treatment.

Authors:  Veronica Ferrucci; Iolanda Boffa; Gina De Masi; Massimo Zollo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-09       Impact factor: 3.000

7.  Antitumor and immunostimulatory activities of a genotype V recombinant attenuated veterinary Newcastle disease virus vaccine.

Authors:  Oscar Antonio Ortega-Rivera; J Luis Quintanar; Susana Del Toro-Arreola; Ángel G Alpuche-Solis; Mayra J Esparza-Araiza; Eva Salinas
Journal:  Oncol Lett       Date:  2017-11-09       Impact factor: 2.967

8.  GDF11/BMP11 as a novel tumor marker for liver cancer.

Authors:  Yong-Hui Zhang; Lian-Hong Pan; Yi Pang; Jin-Xin Yang; Meng-Jia Lv; Feng Liu; Xue-Feng Qu; Xin-Xin Chen; Hua-Jun Gong; Dan Liu; Yong Wei
Journal:  Exp Ther Med       Date:  2018-02-12       Impact factor: 2.447

9.  Epigenetic analysis of FHL1 tumor suppressor gene in human liver cancer.

Authors:  Jun Wang; Fang Huang; Jian Huang; Jindan Kong; Shenglan Liu; Jun Jin
Journal:  Oncol Lett       Date:  2017-09-15       Impact factor: 2.967

10.  Sphingomyelin synthase 2 overexpression promotes cisplatin-induced apoptosis of HepG2 cells.

Authors:  Si Luo; Zhen Pan; Shuang Liu; Shujing Yuan; Nianlong Yan
Journal:  Oncol Lett       Date:  2017-10-31       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.